ScienTek
Denmark, Denmark
ScienTek is a biotechnology company focused on accelerating aptamer discovery through cutting-edge technologies. They offer a platform that enhances precision medicine and drug delivery using engineered single-stranded oligonucleotides, or aptamers, that can effectively bind to and inhibit proteins. Their services range from identifying promising drug targets using comprehensive maps of biological entities to in vitro validation of aptamers. With an impressive 80% success rate for nanomolar binding affinity aptamers, ScienTek employs AI technologies for rapid design, optimization, and screening, making them a leader in the drug discovery landscape.
Company Info
- Founded
- 2025
- Website
- scientek.io/
Only accessible to MedStartr community members.
Join nowWhat do you think of ScienTek?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.